Akari Therapeutics Plc (AKTX) Total liabilities 2022–2023
Akari Therapeutics Plc (AKTX) total liabilities at each fiscal year-end, per SEC filings.
$4.6MFY2023 · since FY2022: $15.6M → $4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $4.6M | -70.7% |
| FY2022 | $15.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AKTX financial trends
AKTX RevenueAKTX Net incomeAKTX Net marginAKTX Gross profitAKTX Gross marginAKTX Operating incomeAKTX Operating marginAKTX Operating cash flowAKTX Free cash flowAKTX Capital expendituresAKTX Return on equityAKTX Stock buybacksAKTX Dividends paidAKTX Total assetsAKTX Shareholders’ equityAKTX overview →